Literature DB >> 26634289

Risk factors associated with competing mortality among patients with head and neck cancer in Japan.

Yukinori Takenaka1, Toshimichi Yasui1, Keisuke Enomoto1, Haruka Miyabe1, Natsue Morizane1, Naoki Ashida1, Kotaro Shimizu1, Masayuki Hirose1, Yoshifumi Yamamoto1, Atsuhiko Uno1.   

Abstract

Conclusions This study demonstrated a high incidence of competing mortality in patients with head and neck cancer (HNC). It identified age to be an independent prognostic factor for non-cancer mortality. These findings contribute to the appropriate treatment selection in clinical settings and study design in clinical trials. Objectives To investigate the incidences of second primary cancer (SPC) and non-cancer mortalities among patients with HNC and reveal the determinant factors for these mortalities. Methods This study reviewed the records of 334 patients with HNC between 2006-2012. The cumulative incidences of HNC, non-cancer, and SPC mortalities were estimated. A Fine and Gray regression model was used to investigate factors associated with cancer and non-cancer mortalities. Results The 5-year cumulative incidences of HNC, SPC, and non-cancer mortalities were 28.0%, 2.5%, and 6.5%, respectively. In univariate analysis, the factors associated with SPC mortality were tumor site and comorbidity, whereas those associated with non-cancer mortality were age, gender, and comorbidity. In multivariate analysis, age (sub-distribution hazard ratio = 2.59) was the independent risk factor for non-cancer mortality.

Entities:  

Keywords:  Head and neck cancer; comorbidity; competing mortality; second primary cancer

Mesh:

Year:  2015        PMID: 26634289     DOI: 10.3109/00016489.2015.1117653

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

1.  Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort.

Authors:  Gustavo Arruda Viani; Alexandre Ciufi Faustino; Anielle Freitas Bendo Danelichen; Fernando Kojo Matsuura; Leonardo Vicente Fay Neves; Marco Henrique Fernandes; Juliana Pavoni Fernandes
Journal:  Rep Pract Oncol Radiother       Date:  2021-02-25

2.  Prognostic Factors Predict Oncological Outcome in Older Patients With Head and Neck Cancer Undergoing Chemoradiation Treatment.

Authors:  Carmen Stromberger; Berna Yedikat; Annekatrin Coordes; Ingeborg Tinhofer; Goda Kalinauskaite; Volker Budach; Sebastian Zschaeck; Jan-Dirk Raguse; Grzegorz Kofla; Max Heiland; Aksana Stsefanenka; Benedicta Beck-Broichsitter; Steffen Dommerich; Carolin Senger; Marcus Beck
Journal:  Front Oncol       Date:  2021-02-23       Impact factor: 6.244

3.  Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy.

Authors:  I Zapata; M Alvarez; R Hidalgo; B Pajares; M J Garcia-Anaya; M D Toledo; J M Trigo; Y Lupiañez-Perez; J A Medina; J Jaime Gomez-Millan
Journal:  BMC Cancer       Date:  2019-12-21       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.